Chronic or intermittent sleep disorders including narcolepsy, REM behavior disorder, sleep apnea, and insomnia afflict nearly 50-70 million people in the United States. Yet the neural mechanisms controlling both normal sleep and its pathologies remain poorly understood. Considerable evidence indicates that mesopontine cholinergic neurons and other neurons at the mesopontine junction are critical for this control and that their disregulation is involved in narcolepsy, REM behavior disorder, Parkinson's disease, supranuclear palsy and depression. The long term goal of this project is to understand the mechanisms regulating activity of these neurons and their functions in regulating sleep and sleep pathologies. Compelling evidence indicates that disruption of the Hypocretin/Orexin (Hcrt/Orx) peptide system results in narcolepsy - a sleep disorder characterized by excessive daytime sleepiness, sleep fragmentation and the intrusion of rapid eye movement sleep behaviors into wakefulness. Building on the findings from previous funding periods, which showed that mesopontine cholinergic neurons and dorsal raphe serotonergic neurons are important targets of these peptides, we will continue to investigate the general hypothesis that Hcrt/Orx peptides regulate both the short- term and long-term excitability of these neurons. We will explicitly test the hypothesis that cholinergic transmission resulting from mesopontine cholinergic neurons contribute the disruptions of waking and sleep in narcoleptic mice and that they promote the entrance into cataplexy but that their activity contributes little to regulating te duration of cataplectic attacks. To do so we will 1) identify the mechanisms underlying a new class of post-synaptic orexin actions post-spike afterhyperpolarization in mesopontine cholinergic neurons and dorsal raphe serotonergic neurons. 2) Explore the impact of the major orexin actions on firing pattern and encoding of inputs by mesopontine cholinergic neurons and dorsal raphe serotonergic neurons. 3) determine whether selective excitation and inhibition of mesopontine cholinergic neurons can regulate arousal and sleep in normal and narcoleptic mice and whether these neurons can trigger cataplexy in narcoleptic mice. These experiments will use whole-cell patch clamp recording, calcium imaging and dynamic clamp methods in brain slices from normal and orexin receptor knockout mice and will utilize optogenetic stimulation methods in normal and narcoleptic mice. Collectively, these results will advance our understanding of the molecular and cellular mechanisms underlying sleep regulation and its pathology.

Public Health Relevance

Sleep disorders such as narcolepsy, REM behavior disorder, sleep apnea, and insomnia afflict 50-70 million people in the United States. Yet the neural mechanisms controlling both normal sleep and its pathologies remain poorly understood. The proposed research will advance our understanding of these mechanisms by elucidating the actions of hypocretin/orexin neuropeptides on brain circuits thought to be critical for regulating arousal and sleep. We will also selectively stimulate and inhibit one of these circuits in normal and narcoleptic mice to gain a better understanding of how the loss of hypocretin/orexin signaling leads to the sleep disorder narcolepsy. In addition to contributing to a better understanding of how sleep and waking are regulated by the brain, clarifying these mechanisms will help identify neural circuits that might be ultimately exploited for therapeutic interventionsin these disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS027881-19
Application #
8654361
Study Section
Neuroendocrinology, Neuroimmunology, Rhythms and Sleep Study Section (NNRS)
Program Officer
He, Janet
Project Start
1991-12-01
Project End
2017-02-28
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
19
Fiscal Year
2014
Total Cost
$665,635
Indirect Cost
$252,197
Name
New York Medical College
Department
Physiology
Type
Schools of Medicine
DUNS #
041907486
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Leonard, C S; Kukkonen, J P (2014) Orexin/hypocretin receptor signalling: a functional perspective. Br J Pharmacol 171:294-313
Kukkonen, J P; Leonard, C S (2014) Orexin/hypocretin receptor signalling cascades. Br J Pharmacol 171:314-31
Kalogiannis, M; Grupke, S L; Potter, P E et al. (2010) Narcoleptic orexin receptor knockout mice express enhanced cholinergic properties in laterodorsal tegmental neurons. Eur J Neurosci 32:130-42
Konduri, G Ganesh; Vohr, Betty; Robertson, Charlene et al. (2007) Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up. J Pediatr 150:235-40, 240.e1